Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 9, 2016 - Issue
Submit an article Journal homepage
120
Views
11
CrossRef citations to date
0
Altmetric
Review

Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa

Christina FotiadouFirst Department of Dermatology-Venereology, Aristotle University Medical School, Thessaloniki, Greece
,
Efstratios VakirlisFirst Department of Dermatology-Venereology, Aristotle University Medical School, Thessaloniki, Greece
&
Dimitrios IoannidesFirst Department of Dermatology-Venereology, Aristotle University Medical School, Thessaloniki, GreeceCorrespondence[email protected]
Pages 367-372 | Published online: 19 Oct 2016

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Daniel J. Lee, Sapna Desai, Emily Laurent & Laura J. Kopplin. (2021) Characterization and Management of Inflammatory Eye Disease in Patients with Hidradenitis Suppurativa. Ocular Immunology and Inflammation 29:7-8, pages 1318-1323.
Read now

Articles from other publishers (10)

Angelo Ruggiero, Fabrizio Martora, Vincenzo Picone, Laura Marano, Gabriella Fabbrocini & Claudio Marasca. (2022) Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review. Biomedicines 10:2, pages 455.
Crossref
Sylke Schneider-Burrus, Athanasia Tsaousi, Sebastian Barbus, Johannes Huss-Marp, Katrin Witte, Kerstin Wolk, Björn Fritz & Robert Sabat. (2021) Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients. Frontiers in Medicine 8.
Crossref
Vijaytha Muralidharan, Pirunthan Pathmarajah, Elizabeth Peterknecht, Erma Qazi, Richard Barlow, Vivek Muralidharan, Anthony Abdullah, Bryan McDonald & Anthony Bewley. (2021) Real life data on the biopsychosocial effects of Adalimumab in the management of hidradenitis suppurativa: A multicenter cross sectional analysis and consideration of a multisystem monitoring approach to follow up. Dermatologic Therapy 34:1.
Crossref
Andrew Hendrix, Zeid Nesheiwat, Arooge Towheed, Vijaywant Brar & Blair P. Grubb. (2021) Adalimumab as a potential treatment for postural orthostatic tachycardia syndrome. HeartRhythm Case Reports 7:1, pages 56-58.
Crossref
P. Sahu, P. Aggarwal, S. Dayal & V. Kumar Jain. (2019) Biologic therapy: a boon for hidradenitis suppurativa-like lesions complicating naevus comedonicus in a prepubertal child. Clinical and Experimental Dermatology 44:3, pages 322-324.
Crossref
Katarzyna Włodarek, Małgorzata Ponikowska, Łukasz Matusiak & Jacek C Szepietowski. (2019) Biologics for hidradenitis suppurativa: an update. Immunotherapy 11:1, pages 45-59.
Crossref
Kevin T. Savage, Kelsey S. Flood, Martina L. Porter & Alexa B. Kimball. (2019) TNF-α inhibitors in the treatment of hidradenitis suppurativa. Therapeutic Advances in Chronic Disease 10, pages 204062231985164.
Crossref
John W. Frew, Jason E. Hawkes & James G. Krueger. (2019) Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Therapeutic Advances in Chronic Disease 10, pages 204062231983064.
Crossref
A. Balato, G. Caiazzo, M.C. Annunziata, C. Marasca, E. Scala, S. Cacciapuoti & G. Fabbrocini. (2018) Anti‐ TNF ‐α therapy modulates mTORC 1 signalling in hidradenitis suppurativa . Journal of the European Academy of Dermatology and Venereology 33:1.
Crossref
Ali Balevi, Pelin Ustuner & Mustafa Özdemir. (2018) The efficacy of adalimumab in the treatment of hidradenitis suppurativa. Dicle Tıp Dergisi 45:1, pages 19-27.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.